Real-Time PCR in HIV/Trypanosoma cruzi Coinfection and Chagas Disease Reactivation
Author Information
Author(s): de Freitas Vera Lúcia Teixeira, da Silva Sheila Cristina Vicente, Sartori Ana Marli, Bezerra Rita Cristina, Westphalen Elizabeth Visone Nunes, Molina Tatiane Decaris, Teixeira Antonio R. L., Ibrahim Karim Yaqub, Shikanai-Yasuda Maria Aparecida
Primary Institution: Faculdade de Medicina, University of São Paulo
Hypothesis
Can quantitative molecular tests effectively monitor Chagas disease reactivation in HIV/Trypanosoma cruzi coinfected patients?
Conclusion
The study found that qRT-PCR can distinguish between HIV/Trypanosoma cruzi coinfected patients with and without Chagas disease reactivation.
Supporting Evidence
- qRT-PCR showed significant differences in parasitemia levels between groups.
- Patients with HIV/T. cruzi reactivation had the highest median parasitemia.
- Correlation was found between HIV viral load and T. cruzi parasitemia.
- CD4+ cell counts were negatively correlated with parasitemia levels.
- qRT-PCR was more sensitive than traditional diagnostic methods.
Takeaway
This study shows a new test that can help doctors find out if a person with HIV and Chagas disease is getting worse, so they can start treatment sooner.
Methodology
The study used quantitative PCR methods to analyze blood samples from patients with chronic Chagas disease and HIV/Trypanosoma cruzi coinfection.
Limitations
The small number of patients with Chagas disease reactivation limited the study's findings.
Participant Demographics
Patients were ≥18 years old, with 57 having chronic Chagas disease and 34 coinfected with HIV.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website